, and Skovde SUMMARY In a population based epidemiological survey of juvenile chronic arthritis (JCA), performed in Western Sweden in 1983, an incidence of 12/100 000 was found. The estimated prevalence was 56/100 000. Subgroup distribution showed a preponderance of mono-and pauciarticular forms. The peak age of onset was between 0 and 4 years of age. Girls predominated over boys in a ratio of 3:2. Overall, 30% were antinuclear antibody (ANA) positive, 9% rheumatoid factor (RF) positive, and eye involvement occurred in 10% of the children. The results suggest differences in population based studies of JCA compared with previously reported hospital based series.
he already at that time speculated about several types of chronic arthritis in childhood. Through the years this heterogeneity has become obvious, with different patterns of clinical presentation, immunological characteristics, and long term prognosis.
Epidemiologic data are conflicting because of the heterogeneity of the disease and the lack of standardised criteria for diagnosing juvenile chronic arthritis and for dividing the children into subgroups. In addition, most incidence and prevalence figures are based on patients cared for at rheumatology clinics and not on population surveys. In the present study a defined population was investigated in an attempt to find frequency figures for juvenile chronic arthritis, both for the hospital cases and for the milder cases seen only by the local paediatrician.
Patients and methods
PATI ENTS
The population base consisted of 400 600 children, Accepted for publication 15 October 1986. Correspondence to Dr B Andersson Gare, Department of Pediatrics 11, Bamkliniken, Ostra sjukhuset, S- Table 5 ). The highest prevalence, reported by the National Health Interview Survey in the USA,'5 probably again reflects the effect of the shorter observation period before diagnosis in North America and the low specificity of the method used: diagnosing arthritis by population questionnaires. Another important factor not discussed in previous reports is assessment of remission. In our survey children not receiving medication and free from symptoms and signs for three years or more were excluded. After our study was completed EULAR proposed a two year period, rather than three years, as a definition of remission (EULAR standing committee, Moscow, 1983).
A bimodal distribution for the age at onset of JCA has been suggested with one peak in the age group below 5 years and another in the 10-16 age group.'0 17 In contrast, we found a single peak in the age group 0-4 years, which was most prominent for the mono-and pauciarticular subgroups. Age at is in agreement with earlier reports.17-21
The differences found compared with results of previous work encourage further epidemiological studies using prospectively collected population based materials followed up over an extended time period, in order to increase our knowledge of disease incidence and prevalence, the natural history of various subgroups, and the factors predicting long term prognosis. 
